ClinicalTrials.Veeva

Menu

Intranasal Diagnostics in Food Allergy: a Feasibility Study (INDY)

Imperial College London logo

Imperial College London

Status

Completed

Conditions

Food Allergy

Treatments

Other: Intranasal challenge with placebo
Other: Intranasal challenge with active substance (food protein)

Study type

Interventional

Funder types

Other

Identifiers

NCT02159833
14SM2069

Details and patient eligibility

About

The investigators will conduct low-dose intranasal allergen challenges on children/adolescents with a diagnosis of food allergy to egg/cow's milk/soya/wheat/peanut. The data will be used to determine the safety and potential utility of intranasal food challenges in the diagnosis of food allergy.

Enrollment

31 patients

Sex

All

Ages

6 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 6 - 17 years old

  • Physician-diagnosis of food allergy on the basis of:

    • Positive oral food challenge to the causative food (conducted under medical supervision) within the last 12 months; OR
    • History of convincing clinical reaction to the causative food within the last 12 months AND positive skin prick test within last 12 months; OR
    • Evidence of >95% likelihood of food allergy (on the basis of serum specific IgE or skin prick test (SPT) 8mm or above to the causative food allergen within past 12 months
  • Written informed consent from parent/guardian, with assent from children aged 8 years and above wherever possible. Participants aged over 16 years will need to provide their owned informed consent.

Exclusion criteria

  • Contraindicated as acutely unwell or current unstable asthma:

    • Acute wheeze in last 72 hours requiring treatment
    • Febrile ≥38.0oC in last 72 hours
    • Recent admission to hospital in last 2 weeks for acute asthma
  • Current medication

    • Use of asthma reliever medication in last 72 hours
    • Recent administration of a medication containing antihistamine within the last 4 days
    • Current oral steroid for asthma exacerbation or course completed within last 2 weeks

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

31 participants in 1 patient group

Intervention
Experimental group
Description:
Intranasal challenge with food protein or vehicle control
Treatment:
Other: Intranasal challenge with placebo
Other: Intranasal challenge with active substance (food protein)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems